Medical isotope production without highly enriched uranium [

"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the m...

Full description

Bibliographic Details
Corporate Author: National Research Council (US . Committee on Medical Isotope Production Without Highlty Enriched Uranium
Format: Book
Language:English
Published: Washington, DC : National Academies Press , c2009
Subjects:
Online Access:NetLibrary
Description
Summary:"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply."
Item Description:Title from electronic title page (viewed June 1, 2009)
Physical Description:1 electronic text (xviii, 202 p.) : digital, GIF, PDF, ill.
Also issued in print.
Format:Adobe Acrobat required for PDF version.
Mode of access: World Wide Web.
Bibliography:Includes bibliographical references
ISBN:0309130395
0309130409 (electronic bk.)
6612239247
9780309130394
9780309130400 (electronic bk.)
9786612239243